Benefits
Cardiovascular benefits via strawberry consumption
Strawberry consumption RCTs (delivering pelargonidin glycosides) show modest cardiovascular benefits: lower total and LDL cholesterol, less LDL oxidation, and lower post-meal triglycerides in overweight adults and in people with features of metabolic syndrome. The strawberry trials that measured blood pressure found no change, and none of them measured endothelial function. The mechanism is partially attributable to pelargonidin among other anthocyanins.
Anti-inflammatory effects (preclinical, strawberry RCTs)
In crossover trials in overweight adults, a strawberry drink taken with a meal lowered the post-meal rise in hsCRP and IL-6. The results are not uniform: a four-week strawberry study in women with metabolic syndrome measured CRP and adiponectin and found no change in either. The NF-κB explanation comes from pelargonidin applied to cells in a dish, not from people.
Glucose metabolism (strawberry trials)
Some strawberry RCTs show improved postprandial glucose control and modest insulin sensitivity improvement. The α-glucosidase inhibition often quoted for pelargonidin-3-glucoside comes from test-tube assays rather than from human trials, so it is a proposed explanation for the effects of strawberry-rich diets rather than a demonstrated one.
Antioxidant via metabolite effects
Pelargonidin and its breakdown product 4-hydroxybenzoic acid show antioxidant activity in test-tube and animal work. Protocatechuic acid, which is often credited to pelargonidin, is really the breakdown product of cyanidin, a different anthocyanidin. In human studies, daily strawberry intake for two to four weeks raised plasma antioxidant capacity and lowered a marker of lipid peroxidation, so the human antioxidant evidence is for the whole fruit rather than for isolated pelargonidin. Mechanism for general 'oxidative stress reduction' claims associated with berry-rich diets.
Skin and UV protection (laboratory studies only)
No animal study has tested pelargonidin on its own against UV skin damage, and there is no human trial of it for skin. The strawberry photoprotection work was done on skin cells in culture, using whole strawberry extract applied to the cells rather than eaten. The proposed route is antioxidant and anti-inflammatory activity.
Mechanism of action
Antioxidant via direct scavenging and Nrf2
Anthocyanidin structure (with hydroxyl groups + flavylium cation) provides direct radical scavenging. Plus activation of Nrf2 transcription factor upregulating endogenous antioxidant defenses. Mechanism for cellular oxidative stress reduction observed with strawberry consumption.
α-Glucosidase inhibition
In test-tube assays, pelargonidin-3-glucoside inhibits α-glucosidase, the enzyme that breaks starch down into sugar. If the same happened in the gut it would slow carbohydrate digestion and blunt the rise in blood sugar after a meal. That step has been shown in the laboratory rather than in people, and it is one proposed contributor to the glucose effects seen with berry consumption.
Metabolite-mediated activity (glucuronides and 4-hydroxybenzoic acid)
Pelargonidin is rapidly converted to glucuronide and sulfate conjugates, and is broken down to 4-hydroxybenzoic acid from the B ring and phloroglucinaldehyde from the A ring. Protocatechuic acid, sometimes quoted in this position, is the corresponding product of cyanidin rather than of pelargonidin. These metabolites persist in plasma longer than the parent anthocyanin and circulate at higher concentrations. May mediate the observed clinical effects more than parent pelargonidin itself. Reframes anthocyanin activity as 'metabolite delivery.'
Endothelial nitric oxide enhancement
Anthocyanins as a class have been shown to raise endothelial nitric oxide synthase (eNOS) activity in cell and animal work. This is a proposed explanation rather than a demonstrated one for pelargonidin: the strawberry trials on this page did not measure endothelial function, and those that measured blood pressure found no change.
NF-κB inhibition and anti-inflammatory cytokine reduction
Pelargonidin and metabolites inhibit NF-κB activation, reducing pro-inflammatory cytokines (TNF-α, IL-6, IL-1β). Mechanism for inflammation reduction in human trials of strawberry-rich diets.
Clinical trials
Single-arm human strawberry feeding study, before and after, with no placebo group (Basu A, Wilkinson M, Penugonda K, Simmons B, Betts NM, Lyons TJ 2009, Nutr J 8:43, doi:10.1186/1475-2891-8-43, PMID 19785767).
16 women with features of metabolic syndrome consumed 50 g of freeze-dried strawberry powder daily for 4 weeks, taken as two cups of strawberry drink with 25 g of powder in each. The paper reports the dose as providing 154 mg of total anthocyanins, which in strawberry are mostly pelargonidin-3-glucoside. Cardiovascular biomarkers measured.
Reduced total cholesterol (-5%) and LDL cholesterol (-6%); reduced lipid peroxidation as malondialdehyde and hydroxynonenal (-14%). No change in blood pressure, HDL, triglycerides or fasting glucose, and no change in the inflammation markers CRP and adiponectin. Demonstrates pelargonidin-rich strawberry consumption has measurable cardiovascular biomarker effects in metabolic syndrome population. Limited by single-center, small sample, no placebo control.
Randomized crossover human trial (Burton-Freeman B, Linares A, Hyson D, Kappagoda T 2010, J Am Coll Nutr 29(1):46-54, doi:10.1080/07315724.2010.10719816).
Randomized single-blind placebo-controlled crossover trial in 24 overweight hyperlipidemic men and women. A strawberry beverage containing 10 g of freeze-dried strawberries, or a matched placebo, was taken daily for 6 weeks in each arm, with a high-fat meal challenge. Post-meal triglycerides and oxidized LDL were measured.
The strawberry beverage lowered post-meal triglycerides and oxidized LDL compared with placebo. This paper did not measure IL-6 or IL-1 beta. The cytokine finding belongs to a separate strawberry crossover trial by the same group (Edirisinghe 2011, Br J Nutr 106(6):913-922, PMID 21736853), in which a strawberry drink taken with a high-carbohydrate, moderate-fat meal lowered post-meal hsCRP, IL-6 and insulin in 24 overweight adults. Supports inclusion of strawberries in mixed meals to reduce postprandial inflammatory spike.
Human bioavailability study (Mullen W, Edwards CA, Serafini M, Crozier A 2008, J Agric Food Chem 56(3):713-719, doi:10.1021/jf072000p, PMID 18211024).
Healthy volunteers ate 200 g of strawberries containing 222 micromol of pelargonidin-3-O-glucoside, with and without cream. Plasma and urine were collected over 24 hours and anthocyanin metabolites measured by HPLC-MS.
Pelargonidin-3-glucoside is the major anthocyanin in strawberry. The main circulating metabolite was a pelargonidin-O-glucuronide, peaking near 274 nmol per liter about an hour after eating, and urinary recovery of anthocyanin metabolites came to roughly 1 percent of the amount eaten. Absorption of the parent compound is very low, on the order of 1 to 2 percent but metabolite-mediated activity may be biologically important. Important context for understanding human pharmacology.